Related Experiment Video
Updated: Aug 9, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Dyskeratosis Congenita (DC) Registry: identification of new features of DC
S Knight1, T Vulliamy, A Copplestone
1Department of Haematology, Imperial College School of Medicine, London, UK.
Insights
Dyskeratosis congenita (DC) is an inherited disorder primarily affecting males, often causing bone marrow failure. The DKC1 gene on the X chromosome is linked to DC, highlighting its role in cell biology.
Area of Science:
- Genetics
- Hematology
- Cell Biology
Background:
- Dyskeratosis congenita (DC) is a rare inherited disorder.
- Classic features include skin pigmentation, nail dystrophy, and mucosal leukoplakia.
- Bone marrow failure is a common and severe complication.
Purpose of the Study:
- To investigate the genetic basis and clinical spectrum of Dyskeratosis Congenita.
- To identify the gene responsible for X-linked DC.
- To understand the role of the identified gene in cell biology and disease pathogenesis.
Main Methods:
- Establishment of a Dyskeratosis Congenita Registry.
- Recruitment of affected families for genetic analysis.
- Linkage analysis to map the responsible gene.
- Positional cloning of the DKC1 gene.
Main Results:
- The majority of patients (76/83) were male, suggesting X-linked inheritance.
- Bone marrow failure occurred in 93% of patients, leading to early mortality in 71%.
- The DKC1 gene located at Xq28 was identified as responsible for X-linked DC.
- Skewed X-chromosome inactivation patterns were observed in female carriers.
Conclusions:
- Dyskeratosis congenita has a significant genetic component, with the DKC1 gene playing a crucial role.
- The DKC1 gene is essential for normal hematopoiesis and broader cell biology.
- Understanding DKC1's function offers insights into DC pathogenesis and potential therapeutic targets.
Abstract:
Dyskeratosis congenita (DC) is an inherited disorder characterized by skin pigmentation, nail dystrophy and mucosal leucoplakia. In 1995 a Dyskeratosis Congenita Registry was established at the Hammersmith Hospital. In the 46 families recruited, 76/83 patients were male, suggesting that the major form of DC is X-linked. As well as a variety of noncutaneous abnormalities, the majority (93%) of patients had bone marrow (BM) failure and this was the principal cause (71%) of early mortality. In addition to BM hypoplasia, some patients also developed myelodysplasia and acute myelod leukaemia. Pulmonary abnormalities were present in 19% of patients. In affected females the phenotype was less severe. Some female carriers of X-linked DC had clinical features. Carriers of X-linked DC showed skewed X-chromosome inactivation patterns (XCIPs), suggesting that cells expressing the normal DC allele have a growth/survival advantage over cells that express the mutant allele. Linkage analysis in multiplex families confirmed that the DKC1 gene, responsible for the X-linked form of DC, is located within Xq28 and facilitated its positional cloning. The high incidence of BM failure in association with a wide range of somatic abnormalities together with the ubiquitous expression of DKC1 suggest that, as well as having a critical role in normal haemopoiesis, this gene has a key role in normal cell biology.
Related Concept Videos
Pleiotropy
Desmosomes
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

